Endovascular Atherectomy Safety and Effectiveness Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT01541774

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
AtheroMed, Inc (from the registry)
Registry
  • NCT NCT01541774
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01541774. Allocation not applicable; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Atherectomy Safety and Effectiveness Study
Acronym
EASE
Condition
Peripheral Vascular Disease
Intervention (Device)
Phoenix Atherectomy System
Lead sponsor
AtheroMed, Inc (class: industry)

Record details

Record id
cardio:ct-nct01541774
Content hash
7bc2563f2bbbaa33ffae52bdda188a43afc745a4f884a3df78fee31696f2362a